surmount-1 trial tirzepatide non-diabetic obesity weight loss SURMOUNT-1: Drastically Reduces in Obese Patients Tirzepatide for maintenance of bodyweight

By targeting appetite regulation, glucose control, and energy balance, cagrilintide may represent an important step forward in managing obesity, type 2 diabetes, and related metabolic conditions ( 1, 3 )

Thats not luck

(00:32:23) Channelopsins: Tools For Understanding & Treating the Mind (00:39:10) Curing Blindness with Channelopsins (00:41:58) Why Karl Became a Scientist (00:47:10) Vagus Nerve In Depression (00:54:12) Challenges To Overcome for Treating Mental Illness with Channelopsins (00:58:34) Using the Dialogue with Patients to Guide Treatment (01:00:52) How Our Eyes Reveal Our Mental Health (01:06:04) Controlling Structures Deep In the Brain (01:08:23) The Most Effective Drugs Often Have the Most Side Effects (01:09:50) Do Psychiatrists Take the Drugs They Prescribe (01:14:15) Moving From Experimental Tools To Novel Treatments (01:16:00) Brain-Machine Interfaces & Neuralink (01:19:30) ADHD & Dr

Community reports suggest subjective changes (energy, recovery) may emerge within 1-2 weeks, with more noticeable effects over 4-6 weeks